This revolutionary new kind of treatment will not just change medicine - It has the potential to eliminate genetic disease from our species.
Dear Fellow Investor,
On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body.
This revolutionary new kind of treatment will not just change medicine -
It has the potential to eliminate genetic disease from our species.
If that sounds like science fiction, consider this -
The Nobel Prize Committee is calling it "The Holy Grail of Medicine"
The Wall Street Journal reports the company is "transforming medicine."
60 Minutes reports the company is "revolutionizing the search for new drugs."
And the biggest drug companies have rushed to invest over a $1 billion in one year alone -
Juno Pharma invested $700 million.
Glaxo SmithKline invested $350 million.
Johnson and Johnson invested $292 million.
That's on top of the $120 million Bill Gates and Google Ventures already invested into this.
The list goes on and on...
Never before has so much money invested in a new treatment so quickly.
And because of that, it's going to create more millionaires than any other single breakthrough in history. More than the internet, more than computers, more than cars.
Investor's Business Daily estimates the market is worth at least $75 billion.
But right now, its stock price is just a tiny fraction of that size.
A special message from the Editor of Capitalist Rise Up: We are often approached by other businesses with special offers for our readers. While many don’t make the cut, the message above is one we believe deserves your consideration.
Email sent by Finance and Investing Traffic, LLC, owner and operator of Capitalist Rise Up
From time to time, we send special emails or offers to readers who chose to opt-in. We hope you find them useful.
If you need personalized assistance or have questions, please respond to this email for a swift response. Contact support@capitalistriseup.com for other inquiries.
Keep up to date with the world of investing and finance by whitelisting us.